Molecular Partners Ag (MOLN) Cash from Financing Activities (2020 - 2026)

Molecular Partners Ag (MOLN) has reported Cash from Financing Activities for 7 consecutive years, with -$372.89 the latest figure, recorded in Q1 2026.

• Quarterly Cash from Financing Activities fell 11.01% year-over-year to -$372.89 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$1.4 million (down 108.57% YoY) and the FY2025 annual result came in at -$1.4 million, down 108.73% from the prior year.
• Cash from Financing Activities improved to -$372.89 in Q1 2026 per MOLN's latest filing, from -$1.4 million in the prior quarter.
• Over the last five years, Cash from Financing Activities for MOLN reached as high as $16.5 million in Q4 2024 and fell as low as -$1.6 million in Q4 2022.
• A 5-year average of $714893.9 and a median of -$343.7 in 2024 frame the typical range for Cash from Financing Activities.
• Annual changes were most pronounced in 2023 — Cash from Financing Activities slumped 523.64% — and 2024, when it jumped 1353.31%.
• Year by year, Cash from Financing Activities stood at -$1.6 million in 2022, then rose by 19.27% to -$1.3 million in 2023, then jumped by 1353.31% to $16.5 million in 2024, then slumped by 108.72% to -$1.4 million in 2025, then jumped by 99.97% to -$372.89 in 2026.
• According to Business Quant data, Cash from Financing Activities over the past three periods registered -$372.89, -$1.4 million, and $680248.3 for Q1 2026, Q4 2025, and Q3 2025 respectively.